BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 2, 2002
View Archived Issues
MMP inhibitors with activity in animal model of periodontitis
Read More
Triacetylshikimic acid: a potent and safe oral antiplatelet agent
Read More
Administration of antarelix associated with acute delay in folliculogenesis, followed by recovery
Read More
Topical GDNF improves behavioral and histological deficits in neonatal rat model of Erb palsy
Read More
Intrauterine growth restriction demonstrated for TNP-470 in later stages of pregnancy
Read More
Inhibitor of TGF-beta activity useful for fibrotic disorders
Read More
Pharmacia studies new kinase inhibitors and potential uses
Read More
Bradykinin antagonists from Pfizer useful for asthma, rhinitis, pain and inflammation
Read More
Several series of antihistamine compounds designed by Ortho-McNeil
Read More
Novel tryptase inhibitors revealed in recent patent by BMS
Read More
Antiangiogenic pyridopyrimidinones in development at Pfizer
Read More
Suberanilohydroxamic acid decreases production of proinflammatory cytokines in vivo
Read More
Novavax presents new results on Estrasorb at Society of Gynecologic Investigation meeting
Read More
Potential of hedgehog antagonists in the treatment of basal cell carcinoma
Read More
New uses for botulinum toxin type A under investigation
Read More
Approvable letter received for Metadate sprinkle administration
Read More
Elan appoints UCB as U.S. copromotion partner for Frova
Read More
Positive results achieved for Atrisone in topical treatment of acne
Read More
FDA sets date to review Biogen's Amevive
Read More
CTV-05 fails to meet primary endpoint in phase II trial
Read More
First thyroid hormone receptor modulator from BMS/Karo Bio collaboration discontinued
Read More
Positive phase IIa results achieved by HCT-1026 in overactive bladder
Read More
Sucampo licenses development and marketing rights to eye drop formulation of tacrolimus
Read More
Dyax obtains rights to inflammation target from Center for Blood Research
Read More
BB-10153 cleared to enter phase II trial
Read More